Visionary Holdings Inc. (GV) | Rumor.io

Visionary Holdings

Attention (50-day avg)0%

Attention rank (50-day avg)#3,382

Bullish sentiment (50-day avg)33%

Price to earnings ratio0

Market capitalization72.9K

Earnings per share-3.66

Dividend yield (TTM)—

Revenue (annual)5M

Net income (annual)-15.7M

Social

What share of all stock conversation is about GV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% -0.01

Jun 24

$GV is expected to have a major move, potentially similar to $Nwgl, with a 3.5 million float and a setup similar to $Nwgl.
Analysts believe $GV could explode fast, with some predicting a 0.5 dollar move or even reaching 1 dollar.
$GV is being watched closely, with some investors calling for a pump, citing a "crazy setup" and a "mega move potential".

Generated by AI

Sentiment

Of the messages about GV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	26.87% -57.4
Bearish	—	—	—	73.13% +57.4

Bullish· Jun 24

$GV is primed for a major move due to its float being identical to $NWGL.
$GV could see a significant price increase, potentially reaching $1, as it is slamming the ask and has a crazy setup.
$GV has the potential to run quickly, similar to $FMFC and $NWGL, and may experience a significant price surge after hours.

Bearish· May 8

The asset's price may experience a short-term dip, as indicated by the suggestion to "wait and see" and the expectation of a price break.
The stock's borrow fee has increased significantly, potentially making it more expensive to short the asset and contributing to its downward momentum.
The asset's price has been impacted by a large number of sell orders, which could continue to weigh on the stock if not resolved.

Generated by AI

Topics

Of the messages about GV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	5.11%
Analysts	—	—	—	29.4%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	60.45%
Technical Analysis	—	—	—	5.04%

Earnings· Mar 14

$GV's Q4 2016 results are expected to be poor, potentially leading to a stock drop.
The company is expected to provide Q1 guidance, which will be crucial for investors.
A strong Q4 2016 performance had set high expectations, making poor Q4 results a significant disappointment.

Announcements· Oct 13

Visionary Holdings (Nasdaq: GV) has secured a global license for breakthrough stem cell technology aimed at diabetes remission and potential complete cure in a $150 billion global market.
The license, for Yike's regenerative stem cell platform, targets both Type 1 and Type 2 diabetes therapies and includes a revenue-sharing model to align commercial incentives.
Visionary Holdings will leverage its international commercialization network to drive the global commercialization of the stem cell technology.

Technical Analysis· Sep 17

$GV has shown a reversal play with a fakeout at the whole dollar, heavy liquidity, and a backside confirmation of a lower high and a loss of the 9-EMA.
The stock has a bullish wedge confirmed with a huge volume spike and an RSI blasting off, indicating a strong momentum move.
The key trigger for a potential trade is a break above $4.11, with the stock potentially pushing back toward the 0.5 zone at $3.10 and reclaiming trend if it can clear intraday resistance with volume.

Generated by AI

Community

Of the messages about GV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	75%	4.49%
Newcomers	—	—	25%	95.51%

Oct 13

The main focus of newcomers is the breakthrough stem cell technology secured by Visionary Holdings, which aims to cure diabetes and has a potential global market value of $150 billion.
Newcomers are discussing the potential for remission and a complete cure for diabetes, particularly in the 540 million patients affected worldwide.
The technology, developed by Yike's, has shown promise in trials for Type 1 and 2 diabetes, with the potential for beta-cell regeneration and an end to insulin hell.

Generated by AI

Gainers Leslies (NASDAQ:LESL) shares increased by 9.4% to $0.95 during Thursday's after-market session. The company's market cap stands at $8.3 million. Visionary Holdings (NASDAQ:GV) shares rose 9.0% to

2mo agoBenzinga

Visionary Holdings' Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.

Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in ChinaNanjing, China--(Newsfile Corp. - July 29, 2026) - Visionary Holdings Inc. (NASDAQ: GV) ("Visionary" or the "Company") today announced that its subsidiary, Nanjing Tuoyuanjian Health Technology Co., Ltd. ("GV Nanjing"), has entered into a Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd....

2mo agoYahoo Finance

Also Discussed

Investors talking about GV also mention

#	Name	Attention
1	VEDU - Visionary Holdings Inc.	——
2	Linkers Industries LimitedLNKS	0%0
3	Silexion Therapeutics Corp.SLXN	0.03%-0.01
4	Semilux International Ltd.SELX	0%new
5	Aclarion, Inc.ACON	0%0
6	Insight Acquisition Corp.AMOD	0%0
7	Interactive Strength Inc.TRNR	0%0
8	Tenon Medical, Inc.TNON	0%new
9	AGM Group Holdings IncAGMH	0%0
10	MNTX - Manitex International, Inc.	——

Visionary Holdings Inc.

Consumer Defensive
Education & Training Services

Visionary Holdings Inc. provides education resources to students worldwide. The company offers large health and elderly care; anti-aging and high-end medical aesthetics health; and artificial intelligence education services. It is also involved in large health and elderly care projects; anti-aging and high-end medical aesthetics projects; and artificial intelligence education field. In addition, the company offers degree-oriented education, Ontario secondary school diploma (OSSD) program, college and undergraduate programs, master's programs, vocational education, education services, AI-assisted learning tools, study and immigration visa services, and other supporting services. The company was formerly known as Visionary Education Technology Holdings Group Inc. and changed its name to Visionary Holdings Inc. in February 2024. The company was incorporated in 2013 and is headquartered in Toronto, Canada.

Website

Location

105445 Apple Creek Boulevard

Toronto, ON, L3R 9X7

Canada

Social

What share of all stock conversation is about GV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% -0.01

Jun 24

$GV is expected to have a major move, potentially similar to $Nwgl, with a 3.5 million float and a setup similar to $Nwgl.
Analysts believe $GV could explode fast, with some predicting a 0.5 dollar move or even reaching 1 dollar.
$GV is being watched closely, with some investors calling for a pump, citing a "crazy setup" and a "mega move potential".

Generated by AI

Sentiment

Of the messages about GV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	26.87% -57.4
Bearish	—	—	—	73.13% +57.4

Bullish· Jun 24

$GV is primed for a major move due to its float being identical to $NWGL.
$GV could see a significant price increase, potentially reaching $1, as it is slamming the ask and has a crazy setup.
$GV has the potential to run quickly, similar to $FMFC and $NWGL, and may experience a significant price surge after hours.

Bearish· May 8

The asset's price may experience a short-term dip, as indicated by the suggestion to "wait and see" and the expectation of a price break.
The stock's borrow fee has increased significantly, potentially making it more expensive to short the asset and contributing to its downward momentum.
The asset's price has been impacted by a large number of sell orders, which could continue to weigh on the stock if not resolved.

Generated by AI

Topics

Of the messages about GV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	5.11%
Analysts	—	—	—	29.4%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	60.45%
Technical Analysis	—	—	—	5.04%

Earnings· Mar 14

$GV's Q4 2016 results are expected to be poor, potentially leading to a stock drop.
The company is expected to provide Q1 guidance, which will be crucial for investors.
A strong Q4 2016 performance had set high expectations, making poor Q4 results a significant disappointment.

Announcements· Oct 13

Visionary Holdings (Nasdaq: GV) has secured a global license for breakthrough stem cell technology aimed at diabetes remission and potential complete cure in a $150 billion global market.
The license, for Yike's regenerative stem cell platform, targets both Type 1 and Type 2 diabetes therapies and includes a revenue-sharing model to align commercial incentives.
Visionary Holdings will leverage its international commercialization network to drive the global commercialization of the stem cell technology.

Technical Analysis· Sep 17

$GV has shown a reversal play with a fakeout at the whole dollar, heavy liquidity, and a backside confirmation of a lower high and a loss of the 9-EMA.
The stock has a bullish wedge confirmed with a huge volume spike and an RSI blasting off, indicating a strong momentum move.
The key trigger for a potential trade is a break above $4.11, with the stock potentially pushing back toward the 0.5 zone at $3.10 and reclaiming trend if it can clear intraday resistance with volume.

Generated by AI

Community

Of the messages about GV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	75%	4.49%
Newcomers	—	—	25%	95.51%

Oct 13

The main focus of newcomers is the breakthrough stem cell technology secured by Visionary Holdings, which aims to cure diabetes and has a potential global market value of $150 billion.
Newcomers are discussing the potential for remission and a complete cure for diabetes, particularly in the 540 million patients affected worldwide.
The technology, developed by Yike's, has shown promise in trials for Type 1 and 2 diabetes, with the potential for beta-cell regeneration and an end to insulin hell.

Generated by AI

Visionary Holdings

Social

Jun 24

Sentiment

Bullish· Jun 24

Bearish· May 8

Topics

Earnings· Mar 14

Announcements· Oct 13

Technical Analysis· Sep 17

Community

Oct 13

News

11 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Leslies (NASDAQ:LESL), Visio

Visionary Holdings' Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.

Also Discussed

Visionary Holdings Inc.

Company Information

Location

News

11 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Leslies (NASDAQ:LESL), Visio

Visionary Holdings' Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.

Also Discussed

Social

Jun 24

Sentiment

Bullish· Jun 24

Bearish· May 8

Topics

Earnings· Mar 14

Announcements· Oct 13

Technical Analysis· Sep 17

Community

Oct 13